Greek pharma industry rails against excessive rebates

In a strongly-worded statement, the Hellenic Association of Pharmaceutical Companies (SFEE) has argued against mandatory rebates on drug expenditure.

The Greek trade body, a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), said that from 2012 onwards, drugmakers had financed the pharmaceutical expenditure of the state through mandatory returns.

Since then, more than 14 billion euros ($15 billion) have been repaid to the state, with the amount increasing every year.